Prelude Capital Management, LLC Eq Rx, Inc. Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.66 - $2.31 $88,979 - $123,820	53,602 Added 179.27%	83,502 $185,000
Q1 2023 May 15, 2023	BUY	$1.8 - $2.83 $53,820 - $84,617	29,900 New	29,900 $58,000
Q2 2022 Aug 15, 2022	SELL	$3.2 - $5.69 $61,334 - $109,060	-19,167 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.8 - $7.39 $53,667 - $141,644	19,167 New	19,167 $79,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.